Simultaneous determination of ABT-888, a poly (ADP-ribose) polymerase inhibitor, and its metabolite in human plasma by liquid chromatography/tandem mass spectrometry
- 1 February 2010
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Chromatography B
- Vol. 878 (3-4), 333-339
- https://doi.org/10.1016/j.jchromb.2009.11.037
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced MalignanciesJournal of Clinical Oncology, 2009
- The PARP inhibitor, ABT-888 potentiates temozolomide: correlation with drug levels and reduction in PARP activity in vivo.2008
- Liquid chromatography–mass spectrometric assay for the quantitation in human plasma of ABT-888, an orally available, small molecule inhibitor of poly(ADP-ribose) polymeraseJournal of Chromatography B, 2008
- Inhibition of Poly(ADP-Ribose) Polymerase Enhances Cell Death and Improves Tumor Growth Delay in Irradiated Lung Cancer ModelsClinical Cancer Research, 2007
- ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor ModelsClinical Cancer Research, 2007
- Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC−MS/MSAnalytical Chemistry, 2003
- Poly(ADP-ribose) Polymerase-2 (PARP-2) Is Required for Efficient Base Excision DNA Repair in Association with PARP-1 and XRCC1Journal of Biological Chemistry, 2002
- Enhanced polyadenosine diphosphate‐ribosylation in cirrhotic liver and carcinoma tissues in patients with hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2001
- Involvement of poly(ADP-ribose) polymerase in base excision repairBiochimie, 1999
- Enhanced expression of poly(ADP‐ribose) synthetase gene in malignant lymphomaAmerican Journal of Hematology, 1991